Northrop Grumman Wins Contract Award and Collaborates With IntegenX to Develop Rapid DNA Biometrics Capability
Published: Oct 12, 2011
MCLEAN, VA--(Marketwire - October 12, 2011) - Northrop Grumman Corporation announced today that it has been awarded a contract from the U.S. Army BOSS-U (Biometrics Operations and Support Services - Unrestricted) program to further develop and supply the IntegenX RapidHIT™ 200 Human DNA Identification System. Previously, IntegenX participated in an invited US Department of Defense (DOD) exercise where the RapidHIT™ system repeatedly delivered correct DNA identifications of individuals in under two hours.
"With the successful demonstration of prototype versions of the RapidHIT 200 System, the BOSS-U award will enable us, in partnership with Northrop Grumman, to accelerate the delivery of field-forward DNA identification to warfighters during 2012," said Stevan Jovanovich, Ph.D., President and CEO of IntegenX Inc. "IntegenX is the first to show that DNA-based human identification can be accomplished in less than two hours using on-site equipment, instead of taking 12 to 15 hours in a laboratory environment, conferring significant tactical advantages in various DOD operational scenarios," added Dr. Jovanovich.
The RapidHIT 200 Human Identification System automates and accelerates the process of producing standardized DNA profiles from cheek swabs, human tissue samples, and other objects with low copy numbers of DNA. DNA profiles generated by the RapidHIT System are used to match collected samples with existing DNA records in domestic and international databases or to expand those databases. Numerous local, state, national and international law enforcement and security agencies use DNA-based human identification to make informed decisions.
About IntegenX Inc.
IntegenX Inc., headquartered in Pleasanton, CA, is a privately-held company that designs, manufactures, and markets solutions to automate tedious and repetitive DNA and RNA workflows. IntegenX's products are engineered to simplify sample processing, enabling powerful analytical tools to be deployed in forward areas and used by personnel with minimal training burden. IntegenX's technology platforms integrate advanced fluidics and robotic capabilities to produce sample-to-answer performance for DNA-based human identity (HID) testing, next generation sequencing, biodefense, and molecular diagnostics applications. For more information, please visit www.integenx.com.
Howard D. Goldstein
Northrop Grumman Information Systems